Health ❯ Pharmaceuticals

Biotechnology

Clinical Trials Drug Development mRNA Technology Vaccine Development Nanomedicine Bioactive Compounds Insulin Production Pharma Companies Women’s Health Innovations FDA Regulations Collaborations Nanobodies Investment in Healthcare RNA Therapeutics Life Sciences Regulatory Approvals Patent Law Covid-19 Vaccines International Collaboration Viral Therapies Biotech Companies Cancer Treatments Antisense Oligonucleotides AI in Medicine Corporate Ethics Antibody Research Cancer Treatment Weight Loss

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke

The case stems from an FDA warning that promotional claims for Anktiva were false or misleading, which drove a roughly 21% stock drop on March 24.

ImmunityBio Investors Face May 26 Deadline in Securities Class Action Over FDA Ad Rebuke

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

Lead-Plaintiff Deadline Nears in MoonLake Securities Suits After SLK Trial Miss

Daré Bioscience Launches Topical Sildenafil Cream for Female Arousal

MoonLake Investors Face Dec. 15 Lead-Plaintiff Deadline in Securities Class Action

MoonLake Investors Courted by Law Firms as Lead‑Plaintiff Deadline Nears in SDNY Securities Case

FDA Clears Arrowhead’s Redemplo for FCS, Marking the Biotech’s First Approval

Rani Therapeutics and Chugai Sign Oral Biologics Collaboration Worth Up to $1.085 Billion

Eupraxia Selects 8 mg Dose After Strong EoE Signals, Expands Phase 2b Trial

Resalis’ miR-22 Antisense Shows Durable Fat Loss in Animals as Phase 1 Trial Continues

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

Albumin-PLGA Nanoparticles Enable Ultrahigh Drug Loading and Six-Month Stability